Hospital staff should use more than one method to detect adverse events and potential adverse events: incident reporting, pharmacist surveillance and local real-time record review may all have a place.

Hospital staff should use more than one method to detect adverse events and potential adverse events: incident reporting, pharmacist surveillance and local real-time record review may all have a place.

BACKGROUND: Over the past five years, in most hospitals in England and Wales, incident reporting has become well established but it remains unclear how well reports match clinical adverse events. International epidemiological studies of adverse events are based on retrospective, multi-hospital case...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Olsen, S, Neale, G, Schwab, K, Psaila, B, Patel, T, Chapman, E, Vincent, C
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2007

Gelijkaardige items

The reasons of the nursing staff to notify adverse events
door: Miriam Cristina Marques da Silva de Paiva, et al.
Gepubliceerd in: (2014-10-01)

Role of the Clinical Pharmacist in Reducing Preventable Adverse Drug Events
door: Bahir A.Mshiemish
Gepubliceerd in: (2017-03-01)

Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events
door: Colleen M. Kingsbury, et al.
Gepubliceerd in: (2024-09-01)

In light of recent events, we may have to see adverse effect profile in new perspective
door: Sahjid Mukhida, et al.
Gepubliceerd in: (2024-11-01)

Internal Strengths for Adverse Life Events
door: Jian Zhao, et al.
Gepubliceerd in: (2024-08-01)

Exploring the causes of adverse events in NHS hospital practice.
door: Neale, G, et al.
Gepubliceerd in: (2001)

Unveiling unexpected adverse events: post-marketing safety surveillance of gilteritinib and midostaurin from the FDA Adverse Event Reporting database
door: Tingting Jiang, et al.
Gepubliceerd in: (2025-01-01)

Preventing drug-related adverse events following hospital discharge: the role of the pharmacist
door: Nicholls J, et al.
Gepubliceerd in: (2017-02-01)

Failure to obtain informed consent should also be considered an adverse event
door: Gabriel M. Fonseca, et al.
Gepubliceerd in: (2020-06-01)

Adverse events in British hospitals: preliminary retrospective record review.
door: Vincent, C, et al.
Gepubliceerd in: (2001)

Case record review of adverse events: a new approach.
door: Woloshynowych, M, et al.
Gepubliceerd in: (2003)

Adverse event management
door: Aline Gonzalez Vigani

The Adverse Event Paradox
door: Thomas Milovac
Gepubliceerd in: (2022-05-01)

Consumers’ adverse drug event reporting via community pharmacists: three stakeholder perception
door: Tanattha Kitisopee, et al.
Gepubliceerd in: (2022-12-01)

Embedding surveillance into clinical care to detect serious adverse events in pregnancy
door: Seale, A, et al.
Gepubliceerd in: (2015)

Surveillance on the adverse events following immunization with the pentavalent vaccine in Zhejiang, China
door: Xuejiao Pan, et al.
Gepubliceerd in: (2022-01-01)

PrePex circumcision surveillance: Adverse events and analgesia for device removal.
door: Limakatso Lebina, et al.
Gepubliceerd in: (2018-01-01)

Adverse Events of Antiepileptic Drugs Using Indonesian Version of Liverpool Adverse Events Profile
door: Astri Budikayanti, et al.
Gepubliceerd in: (2018-01-01)

Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
door: Ming-Tao Wen, et al.
Gepubliceerd in: (2024-08-01)

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
door: Bin Zhao, et al.
Gepubliceerd in: (2018-10-01)

AE-GPT: Using Large Language Models to extract adverse events from surveillance reports-A use case with influenza vaccine adverse events.
door: Yiming Li, et al.
Gepubliceerd in: (2024-01-01)

Adverse events following immunization among the elderly having booster COVID-19 vaccine: an active surveillance in Guiyang city
door: Na YU, et al.
Gepubliceerd in: (2022-09-01)

Adverse events in patients initiated on dabigatran etexilate therapy in a pharmacist-managed anticoagulation clinic
door: Donaldson M, et al.
Gepubliceerd in: (2013-06-01)

Understanding and responding to adverse events.
door: Vincent, C
Gepubliceerd in: (2003)

Minor Adverse Events Postcolonoscopy
door: Catherine Dubé
Gepubliceerd in: (2014-01-01)

Evaluating adverse events in databases
door: Katie Lovell, et al.
Gepubliceerd in: (2023-10-01)

Adverse Events of DOACs in Children
door: Alessandra Bosch, et al.
Gepubliceerd in: (2022-07-01)

Analysis of postmarketing neuropsychiatric adverse events of avapritinib based on the FDA adverse event reporting system
door: Wei Mao, et al.
Gepubliceerd in: (2025-01-01)

Analysis of post-market adverse events of tafamidis base on the FDA adverse event reporting system
door: Fan Wu, et al.
Gepubliceerd in: (2024-06-01)

Adverse event profiles of microscopic colitis in the Japanese Adverse Drug Event Report (JADER) database
door: Kaito Yamashiro, et al.
Gepubliceerd in: (2022-10-01)

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
door: Han N, et al.
Gepubliceerd in: (2021-08-01)

Assessing taxane-associated adverse events using the FDA adverse event reporting system database
door: Dong-Hui Lao, et al.
Gepubliceerd in: (2021-06-01)

Surveillance for adverse events following immunization in Hebei Province, China, 2018-2020
door: Li Sun, et al.
Gepubliceerd in: (2024-12-01)

Reinforcing Surveillance for Vaccine-Associated Adverse Events: The Advisory Committee on Causality Assessment
door: Robert Pless, et al.
Gepubliceerd in: (1996-01-01)

Surveillance on the adverse events following immunization in Dazu District of Chongqing， 2016‒2020
door: WANG Qian, et al.
Gepubliceerd in: (2022-04-01)

Barriers to COVID-19 vaccine surveillance: the issue of under-reporting adverse events
door: Yunha Noh, et al.
Gepubliceerd in: (2023-06-01)

Public Health Surveillance for Adverse Events Following COVID-19 Vaccination in Africa
door: AbdulAzeez Adeyemi Anjorin, et al.
Gepubliceerd in: (2022-04-01)

Active surveillance study of adverse events following immunisation of children in the Czech Republic
door: Jana Danova, et al.
Gepubliceerd in: (2017-02-01)

Adverse event versus medication error: perceptions of nursing staff acting in intensive care
door: Patrícia Cabral Ferreira, et al.
Gepubliceerd in: (2014-03-01)

Adverse event versus medication error: perceptions of nursing staff acting in intensive care
door: Patrícia Cabral Ferreira, et al.
Gepubliceerd in: (2014-03-01)